Showing results (321-330 of 422) with videos related to

Sort By:
Pageof 43
Environmental Health Perspectives|April 21, 2015
Maternal Polybrominated Diphenyl Ether (PBDE) Exposure and Thyroid Hormones in Maternal and Cord Sera: The HOME Study, Cincinnati, USAAnn M Vuong, Glenys M Webster, Megan E Romano, et al.
Environmental Research|May 16, 2016
Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeedingMegan E Romano, Yingying Xu, Antonia M Calafat, et al.
International Journal of Hygiene and Environmental Health|March 9, 2025
Prenatal per- and polyfluoroalkyl substances and blood pressure trajectories in the New Hampshire Birth Cohort StudyYuting Wang, Elizabeth C Anderson, Caitlin G Howe, et al.
Environment International|November 15, 2019
Exposures to chemical mixtures during pregnancy and neonatal outcomes: The HOME studyGeetika Kalloo, Gregory A Wellenius, Lawrence McCandless, et al.
International Journal of Hygiene and Environmental Health|April 3, 2018
Maternal urinary phthalate metabolites during pregnancy and thyroid hormone concentrations in maternal and cord sera: The HOME StudyMegan E Romano, Melissa N Eliot, R Thomas Zoeller, et al.
Environmental Research|June 24, 2017
Maternal serum PFOA concentration and DNA methylation in cord blood: A pilot studySamantha L Kingsley, Karl T Kelsey, Rondi Butler, et al.
Hormones and Behavior|November 21, 2017
Associations of early life urinary triclosan concentrations with maternal, neonatal, and child thyroid hormone levelsJoseph M Braun, Aimin Chen, Andrew Hoofnagle, et al.
Chemosphere|April 9, 2023
Metals and per- and polyfluoroalkyl substances mixtures and birth outcomes in the New Hampshire Birth Cohort Study: Beyond single-class mixture approachesGyeyoon Yim, Glen McGee, Lisa Gallagher, et al.
Environmental Health : a Global Access Science Source|April 13, 2017
Variability and predictors of urinary concentrations of organophosphate flame retardant metabolites among pregnant women in Rhode IslandMegan E Romano, Nicola L Hawley, Melissa Eliot, et al.
Cancer Immunology, Immunotherapy : CII|May 21, 2022
Treatment with a retinoic acid-inducible gene I (RIG-I) agonist as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: results from two phase 1 studiesV Moreno, E Calvo, M R Middleton, et al.
Pageof 43